AEON Biopharma, Inc.
AEON · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $21 | $39,954 | $202 | $202 |
| - Cash | $0 | $5 | $10 | $5 |
| + Debt | $13 | $0 | $132 | $87 |
| Enterprise Value | $34 | $39,949 | $324 | $284 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$28 | -$53 | -$48 | -$37 |
| % Margin | – | – | – | – |
| Net Income | $42 | -$385 | -$53 | -$56 |
| % Margin | – | – | – | – |
| EPS Diluted | 72.93 | -4.99 | -27.25 | -31.73 |
| % Growth | 1,561.5% | 81.7% | 14.1% | – |
| Operating Cash Flow | -$20 | -$48 | -$36 | -$28 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$20 | -$48 | -$36 | -$29 |